BE901073A - Composition antidiuretique a usage oral. - Google Patents

Composition antidiuretique a usage oral.

Info

Publication number
BE901073A
BE901073A BE0/214019A BE214019A BE901073A BE 901073 A BE901073 A BE 901073A BE 0/214019 A BE0/214019 A BE 0/214019A BE 214019 A BE214019 A BE 214019A BE 901073 A BE901073 A BE 901073A
Authority
BE
Belgium
Prior art keywords
composition
oral use
antidiuretic
dosage form
antidiuretic composition
Prior art date
Application number
BE0/214019A
Other languages
English (en)
Original Assignee
Ferring Service Ct N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20353381&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE901073(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Service Ct N V filed Critical Ferring Service Ct N V
Publication of BE901073A publication Critical patent/BE901073A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Composition antidiurétique sous forme dosée à usage oral pour l'etre humain qui comprend une quantité antidiurétiquement efficace de 1-désamino-8-D-arginine vasopressine (DDAVP) et un excipient pharmaceutiquement acceptable. La composition est capable de se dissoudre et d'etre absorbée dans le tractus gastro-intestinal. La composition est présentée sous forme de comprimé, de capsule ou de toute autre forme dosée à usage oral et contient en général environ 200 microgrammes de principe actif par dose unitaire.
BE0/214019A 1983-11-18 1984-11-16 Composition antidiuretique a usage oral. BE901073A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8306367A SE8306367L (sv) 1983-11-18 1983-11-18 Antidiuretiskt verkande farmaceutiskt preparat

Publications (1)

Publication Number Publication Date
BE901073A true BE901073A (fr) 1985-03-15

Family

ID=20353381

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214019A BE901073A (fr) 1983-11-18 1984-11-16 Composition antidiuretique a usage oral.

Country Status (19)

Country Link
US (1) US5047398A (fr)
EP (1) EP0163723B1 (fr)
KR (1) KR930003332B1 (fr)
AU (1) AU577338B2 (fr)
BE (1) BE901073A (fr)
CA (1) CA1232839A (fr)
DE (1) DE3482028D1 (fr)
DK (1) DK168515B1 (fr)
FI (1) FI844540L (fr)
IE (1) IE57989B1 (fr)
IL (1) IL73523A (fr)
IN (1) IN159607B (fr)
IT (1) IT1206233B (fr)
NZ (1) NZ210245A (fr)
OA (1) OA08164A (fr)
PT (1) PT79513B (fr)
SE (1) SE8306367L (fr)
WO (1) WO1985002119A1 (fr)
ZA (1) ZA848965B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005661A1 (fr) * 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Compositions pharmaceutiques a base de vasopressine
US5350766A (en) * 1992-12-18 1994-09-27 New York Medical College Method for the prevention and/or palliation of the complications of diabetes using N-alpha orginine acetyl
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
EP0710243B1 (fr) * 1993-06-29 2000-06-14 Ferring B.V. Synthese de peptides cycliques
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
EP2316468A1 (fr) 2002-02-22 2011-05-04 Shire LLC Système de distribution et méthodes de protection et d'administration de dextroamphetamine
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ATE291419T1 (de) * 2003-04-30 2005-04-15 Ferring Bv Feste dosierungsform mit desmopressin
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
ATE301990T1 (de) * 2003-07-25 2005-09-15 Ferring Bv Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
PT1530967E (pt) 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
WO2009021007A1 (fr) 2007-08-06 2009-02-12 Serenity Pharmaceuticals Corporation Procédés et dispositifs pour l'administration de médicament desmopressine
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
NO3085381T3 (fr) 2008-05-21 2018-09-15
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
CA2765221C (fr) 2009-06-18 2017-10-03 Allergan, Inc. Administration sure de desmopressine
US12214010B2 (en) 2023-04-04 2025-02-04 Tulex Pharmaceuticals Inc. Desmopressin oral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH442342A (de) * 1964-07-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Polypeptids
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids

Also Published As

Publication number Publication date
IL73523A (en) 1989-02-28
FI844540A0 (fi) 1984-11-19
IL73523A0 (en) 1985-02-28
ZA848965B (en) 1985-10-30
NZ210245A (en) 1989-02-24
EP0163723B1 (fr) 1990-04-25
DE3482028D1 (de) 1990-05-31
DK546284A (da) 1985-05-19
CA1232839A (fr) 1988-02-16
OA08164A (en) 1987-03-31
PT79513B (en) 1986-11-18
FI844540A7 (fi) 1985-05-19
IN159607B (fr) 1987-05-30
SE8306367L (sv) 1985-05-19
IE57989B1 (en) 1993-06-02
IE842951L (en) 1985-05-18
DK168515B1 (da) 1994-04-11
US5047398A (en) 1991-09-10
AU3673484A (en) 1985-06-03
PT79513A (en) 1984-12-01
EP0163723A1 (fr) 1985-12-11
KR850700109A (ko) 1985-10-25
KR930003332B1 (ko) 1993-04-26
SE8306367D0 (sv) 1983-11-18
WO1985002119A1 (fr) 1985-05-23
EP0163723A4 (fr) 1986-04-02
IT8409544A0 (it) 1984-11-19
AU577338B2 (en) 1988-09-22
IT1206233B (it) 1989-04-14
DK546284D0 (da) 1984-11-16
FI844540L (fi) 1985-05-19

Similar Documents

Publication Publication Date Title
SE8306367L (sv) Antidiuretiskt verkande farmaceutiskt preparat
EA200200126A1 (ru) Гидродинамически сбалансированная пероральная система доставки лекарства
KR850700212A (ko) 서방성 약제학적 캼셀제
CA2112679A1 (fr) Forme pharmaceutique pour la liberation rapide d'un medicament
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE3686936D1 (de) Am zielorgan wirkendes enterales abgabesystem.
ATE522211T1 (de) Stabilisierte fibrat-mikropartikel
HUP9802339A2 (hu) Darifenacint tartalmazó gyógyászati készítmények
KR950031069A (ko) 골손실의 억제 및 혈청 콜레스테롤의 강하 방법
RU99118887A (ru) Применение ингибиторов желудочно-кишечной липазы
CA2038744A1 (fr) Composition pharmaceutique contenant un medicament legerement hydrosoluble
CA2304948A1 (fr) Composition pharmaceutique pour le traitement d'une maladie intestinale inflammatoire (ibd)
BR9807992A (pt) Comprimidos para engolir os quais compreendem paracetamol
KR910009715A (ko) 요오드 함량이 높은 비이온성 x-선 조영제
KR970061249A (ko) 골다공증을 치료 또는 방지하기 위한 조성물
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
KR890004705A (ko) 항바이러스성 제제
FI89240B (fi) Anvaendning av tillsatsmedel foer oekning av ibuprofens absorptionshastighet
KR870009716A (ko) 클로르페니라민 제형
FR2374044A1 (fr) Agent anti-diabetique oral contenant une sulfonyluree et une kinine
Lieber et al. Complications resulting from renal failure in patients with liver disease
RU93004785A (ru) Твердые капсулы окфосфата цитарабина
ES283591Y (es) Una tableta de dosificacion farmaceutica adecuada para administracion oral

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *FERRING SERVICE CENTER N.V.

Effective date: 20041116